ITCI
Intra-Cellular Therapies Inc
Price:  
65.62 
USD
Volume:  
633,790.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ITCI Relative Valuation

-119.7%
Upside

As of 2024-05-29, the Relative Valuation of Intra-Cellular Therapies Inc (ITCI) is (12.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 65.62 USD, the upside of Intra-Cellular Therapies Inc based on Relative Valuation is -119.7%.

The range of the Relative Valuation is (9.83) - (14.16) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 5.6x - 13.5x 9.2x
Forward P/E multiples 9.4x - 20.7x 15.4x
Fair Price (9.83) - (14.16) (12.92)
Upside -115.0% - -121.6% -119.7%
65.62 USD
Stock Price
(12.92) USD
Fair Price

ITCI Relative Valuation - Historical P/E Data

Date P/E
2024-05-28 -62.45
2024-05-24 -62.38
2024-05-23 -63.17
2024-05-22 -64.05
2024-05-21 -63.76
2024-05-20 -62.17
2024-05-17 -61.86
2024-05-16 -63.32
2024-05-15 -63.61
2024-05-14 -62.54
2024-05-13 -63.12
2024-05-10 -61.82
2024-05-09 -62.39
2024-05-08 -63.76
2024-05-07 -67.77
2024-05-06 -67.58
2024-05-03 -65.48
2024-05-02 -66.94
2024-05-01 -69.22
2024-04-30 -68.34
2024-04-29 -68.81
2024-04-26 -69.72
2024-04-25 -68.65
2024-04-24 -69.59
2024-04-23 -70.44
2024-04-22 -70.94
2024-04-19 -68.88
2024-04-18 -68.52
2024-04-17 -72.99
2024-04-16 -75.98
2024-04-15 -61.63
2024-04-12 -62.70
2024-04-11 -64.69
2024-04-10 -64.03
2024-04-09 -65.31
2024-04-08 -64.43
2024-04-05 -65.14
2024-04-04 -63.96
2024-04-03 -64.07
2024-04-02 -63.45
2024-04-01 -64.97
2024-03-28 -65.86
2024-03-27 -66.35
2024-03-26 -64.08
2024-03-25 -64.69
2024-03-22 -65.69
2024-03-21 -65.08
2024-03-20 -63.96
2024-03-19 -62.29
2024-03-18 -62.21